UNLIMITED TURBO SHORT - VIRBAC Share Price

Certificat

8FGNB

FRBNPP06BU90

Market Closed - Euronext Paris 10:00:01 20/05/2024 pm IST
0.55 EUR +7.84% Intraday chart for UNLIMITED TURBO SHORT - VIRBAC
Current month-6.78%
1 month+71.88%
Date Price Change
20/24/20 0.55 +7.84%
17/24/17 0.51 +10.87%
16/24/16 0.46 +21.05%
15/24/15 0.38 -2.56%
14/24/14 0.39 -17.02%

Real-time Euronext Paris

Last update May 20, 2024 at 10:00 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying VIRBAC
IssuerLogo Issuer BNP Paribas BNP Paribas
8FGNB
ISINFRBNPP06BU90
Date issued 03/01/2024
Strike 395.4
Maturity Unlimited
Parity 100 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.815
Lowest since issue 0.275

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
350 EUR
Average target price
372.4 EUR
Spread / Average Target
+6.41%
Consensus
  1. Stock Market
  2. Certificates
  3. 8FGNB Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW